Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.70 |
| ▸ | MEN1 | O00255 | 3/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.64 |
| ▸ | CASP3 | P42574 | 1/20 | 0.64 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.64 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.63 |
| ▸ | NPC1 | O15118 | 3/20 | 0.63 |
| ▸ | RAB9A | P51151 | 3/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.63 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | CRHBP | P24387 | 1/20 | 0.61 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.56 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.56 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7565510 | 0.90 | RAB9A (0.71) | MAPTSMN1; SMN2NPC1RAB9AKDM4E | |
| SCHEMBL15996898 | 0.88 | KCNQ3 (0.70) | MAPTMEN1KMT2ACASP3TRPV1 | |
| SCHEMBL19938056 | 0.86 | SMN1; SMN2 (0.67) | MAPTMEN1KMT2ACASP3TRPV1 | |
| SCHEMBL1577955 | 0.85 | MEN1 (0.59) | MAPTMEN1KMT2ASMN1; SMN2NPC1 | |
| SCHEMBL9146676 | 0.85 | LMNA (0.68) | MAPTSMN1; SMN2NPC1RAB9AKDM4E | |
| SCHEMBL7565512 | 0.85 | RAB9A (0.70) | MAPTSMN1; SMN2NPC1RAB9AKDM4E | |
| SCHEMBL1719720 | 0.85 | SMN1; SMN2 (0.71) | MAPTSMN1; SMN2NPC1RAB9AKDM4E | |
| SCHEMBL11790359 | 0.85 | RAB9A (0.65) | MAPTSMN1; SMN2NPC1RAB9AKDM4E | |
| SCHEMBL3826853 | 0.84 | RAB9A (0.52) | MAPTCASP3SENP7SMN1; SMN2NPC1 | |
| SCHEMBL352811 | 0.83 | RAB9A (0.63) | MAPTMEN1KMT2ASMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3508473-B1 | METHOD FOR PRODUCING CARBAMIC ACID ESTER | AIST (JP) | 2021-05-26 | — | — | EP | disclosed |
| US-10752579-B2 | Production method of carbamic acid ester | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2020-08-25 | — | — | US | disclosed |
| EP-3508473-A1 | METHOD FOR PRODUCING CARBAMIC ACID ESTER | National Institute of Advanced Industrial Science and Technology (JP) | 2019-07-10 | — | — | EP | disclosed |
| US-20190185420-A1 | PRODUCTION METHOD OF CARBAMIC ACID ESTER | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2019-06-20 | — | — | US | disclosed |
| US-8569267-B2 | Tetracyclic tetrahydrofuran derivatives containing cyclic amine side chain | JANSSEN PHARMACEUTICA, NV (BE) | 2013-10-29 | — | — | US | disclosed |
| US-8163753-B2 | 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-04-24 | — | — | US | disclosed |
| US-20080262076-A1 | Novel Tetracyclic Tetrahydrofuran Derivatives Containing Cyclic Amine Side Chain | JANSSEN PHARMACEUTICA, NV (BE) | 2008-10-23 | — | — | US | disclosed |
| US-20080262076-A1 | Novel Tetracyclic Tetrahydrofuran Derivatives Containing Cyclic Amine Side Chain | JANSSEN PHARMACEUTICA, NV (BE) | 2008-10-23 | — | — | US | disclosed |
| EP-1678185-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS | OTSUKA PHARMA CO LTD (JP) | 2008-10-08 | — | — | EP | disclosed |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | OTSUKA PHAMACEUTICAL CO., LTD. (JP) | 2008-05-22 | — | — | US | disclosed |
| US-4973697-A | 2-halopyridine-6-sulfonic acid and its salt | ONODA CEMENT CO., LTD. (JP) | 1990-11-27 | — | — | US | disclosed |
| EP-0393462-A2 | 2-halopyridine-6-sulfonic acid and its salt | ONODA CEMENT COMPANY, LTD. (JP) | 1990-10-24 | — | — | EP | disclosed |
| EP-0341019-A2 | Polyether antibiotic | ELI LILLY AND COMPANY (US) | 1989-11-08 | — | — | EP | disclosed |
| US-4683201-A | Antibiotic A80190-producing Actinomadura oligospora and process | ELI LILLY AND COMPANY (US) | 1987-07-28 | — | — | US | disclosed |
| US-4634704-A | HISTAMINE AND SEROTONINE ANTAGONISTS | JANSSEN PHARMACEUTICA, N.V. (BE) | 1987-01-06 | — | — | US | disclosed |
| CN-85108210-A | Preparation A80190 antibiotic method | — | 1986-12-03 | — | — | CN | disclosed |
| EP-0184291-A2 | Polyether antibiotic A80190 | ELI LILLY AND COMPANY (US) | 1986-06-11 | — | — | EP | disclosed |
| US-4582822-A | ANIMAL FEED ADDITIVES | ELI LILLY AND COMPANY (US) | 1986-04-15 | — | — | US | disclosed |
| US-4294925-A | FERMENTATION, AEROBIC PROCESSES | HOFFMANN-LA ROCHE INC. (US) | 1981-10-13 | — | — | US | disclosed |
| US-4263427-A | REACTING HYDROXYL WITH ISOCYANATE TO OBTAIN ANTIBIOTICS | HOFFMANN-LA ROCHE INC. (US) | 1981-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080262076-A1 | Novel Tetracyclic Tetrahydrofuran Derivatives Containing Cyclic Amine Side Chain | HTR2C, HTR2A, HTR5A | MAPT 3030/4885MEN1 4320/4885KMT2A 1892/4885 |
| US-20080119478-A1 | 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis | NR2C2, NR0B2, NR4A2 | MAPT 4299/4885MEN1 4525/4885KMT2A 3324/4885 |
| US-20190185420-A1 | PRODUCTION METHOD OF CARBAMIC ACID ESTER | CA2, CA7, CA4 | MAPT 2148/4885MEN1 2437/4885KMT2A 243/4885 |
| US-10752579-B2 | Production method of carbamic acid ester | CA2, CA7, CA4 | MAPT 2148/4885MEN1 2437/4885KMT2A 243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.